Vimarsana
Biggest News Aggregation in the World

Page 14 - Dave Fredrickson News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dave Fredrickson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dave Fredrickson Today - Breaking & Trending Today

FDA Approves Olaparib Plus Abiraterone, Prednisone for Metastatic Castration-Resistant Prostate Cancer - Vimarsana News

FDA Approves Olaparib Plus Abiraterone, Prednisone for Metastatic Castration-Resistant Prostate Cancer

Investigators previously reported a statistically significant improvement in radiographic progression-free survival in the full intention-to-treat population of adults with deleterious or suspected deleterious BRCA-mutated metastatic castration-resistant prostate cancer.

Acalabrutinib Receives Approval in China for Relapsed/Refractory Mantle Cell Lymphoma - Vimarsana News

Acalabrutinib Receives Approval in China for Relapsed/Refractory Mantle Cell Lymphoma

Acalabrutinib has received conditional approval from the National Medical Products Administration in China for the treatment of patients with mantle cell lymphoma who have received at least one prior therapy.

Rose Joy Crutchfield Sundberg: 1932-2023 - Vimarsana News

Rose Joy Crutchfield Sundberg: 1932-2023

Rose Joy Crutchfield Sundberg peacefully returned to her Creator on Feb. 25, 2023, at the age of 90. She was surrounded by family that loves...

AstraZeneca BTK inhibitor tablet approved in EU for leukaemia - Vimarsana News

AstraZeneca BTK inhibitor tablet approved in EU for leukaemia

The tablet formulation for AZ's BTK inhibitor has gained EU approval for co-administration with gastric acid-reducing agents in leukaemia.

Investegate |AstraZeneca PLC Announcements | AstraZeneca PLC: Final Results - Vimarsana News

Investegate |AstraZeneca PLC Announcements | AstraZeneca PLC: Final Results

Investegate announcements from AstraZeneca PLC, Final Results